Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Diabetic Retinopathy

Trial Information

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Official Title: A Phase 3 Safety and Efficacy Study of Vitreosolve® for Four Ophthalmic Intravitreal Injections For Inducing Posterior Vitreous Detachment in Retinopathy Patients.

Summary

The purpose of this study is to determine the safety and efficacy of Vitreosolve® in diabetic retinopathy patients.

Phase: Phase 3

Sponsor: Vitreoretinal Technologies, Inc.

Overall Contacts:

Philip N Calvillo
949-753-1008 ext. 120

Locations (5)

Country State City Zip Facility and Contact
India AP Vizag LVPEI
India Kochi Amrita
Mexico Coyoacan San Lucas La Ceguera
Mexico DF Mexico City Conde De Valenciana
Mexico Neuvo Leon Monterrey Hidalgo

NCT ID:NCT00908778

Date Last Changed: October 19, 2009